Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2/PHASE3
11 participants
INTERVENTIONAL
2021-08-07
2022-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise therapy
8 weeks personalized, multi-modal exercise with focus on lower extremity
* Initial consultation with recommendations for general physical activity
* Brochure with exercise recommendations
* 2x per week multi-modal group-based and supervised exercise (endurance, strength, mobility, coordination)
* week 1 and 2 supervised, week 3 and 4 partially supervised, week 5 and 6 only one supervised session, week 7 and 8 last two sessions supervised
Exercise therapy
8 weeks personalized, multi-modal exercise with focus on lower extremity
Information group
* Initial consultation with recommendations for general physical activity
* Brochure with exercise recommendations.
Information
* Initial consultation with recommendations for general physical activity
* Brochure with exercise recommendations.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise therapy
8 weeks personalized, multi-modal exercise with focus on lower extremity
Information
* Initial consultation with recommendations for general physical activity
* Brochure with exercise recommendations.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Completion of acute cancer treatment and receiving follow-up care in Essen (University Hospital Essen)
* At least 12 months post endoprosthesis implantation
* Signed informed consent (Parents and Patient)
Exclusion Criteria
* time post implantation \<12 months
* Medical condition that limits participation in one of the study arms
* Inability to follow the training-protocol
15 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruhr University of Bochum
OTHER
Universität Duisburg-Essen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Miriam Götte
Principal investigator, Head of exercise oncology group
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Miriam Götte, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Essen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Essen
Essen, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Basteck S, Guder WK, Dirksen U, Krombholz A, Streitburger A, Reinhardt D, Gotte M. Effects of an Exercise Intervention on Gait Function in Young Survivors of Osteosarcoma with Megaendoprosthesis of the Lower Extremity-Results from the Pilot Randomized Controlled Trial proGAIT. Curr Oncol. 2022 Oct 14;29(10):7754-7767. doi: 10.3390/curroncol29100613.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
proGAIT
Identifier Type: -
Identifier Source: org_study_id